PIAS2 promotes sumoylation of α-synuclein, which counteracts ubiquitin-mediated degradation and promotes aggregation. PD brains show increased levels of PIAS2 and sumoylated α-synuclein. The gene discussed is PIAS2; the disease is Parkinson disease.